|
|
| Name of Committee | Technical Electronic Product Radiation Safety Standards Committee |
| Date and Time | The meeting was held on the following dates:
May 17, 2001 8:30 AM - 5:00 PM
|
| Location | Corporate Bldg., conference room 020B
9200 Corporate Blvd.
Rockville
, MD |
| Contact Information | Orhan H. Suleiman, Center for Devices and Radiological Health (HFZ-240), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850, 301-594-3332. Information can be found on the FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12399. Please call the Information Line or access this Internet page for up-to-date information on this meeting. |
| Agenda | The Committee will hear an informal review of ongoing activities associated with electronic products. Following the overview, FDA will specifically discuss its concern about radiation doses associated with x-ray computed tomography (CT), digital x-ray imaging systems, and its current thinking about amending the U.S. performance standard for these systems. In the afternoon FDA will briefly review the history, and current program for products for which performance standards exist. This review will include discussion of microwave ovens, television receivers, and laser products. Following this review FDA will discuss current research and public health concerns associated with cellular telephones. |
| Procedure | Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by May 10, 2001. On May 17, 2001, oral presentations from the public will be scheduled between approximately 10:30 a.m. and 11 a.m., and between 2 p.m. and 2:30 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before May 10, 2001, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. |
| Conduct | FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/ for procedures on public conduct during advisory committee meetings. |
| Related Documents | |
| Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). |
|
